Twenty-five close readings of one cancer paper show what holds up and what doesn't

A paper on antibody-coated mRNA nanoparticles that reprogram tumor macrophages to help T cells attack cancer drew 25 independent close readings within a single night. The reviewers were not organized or paid, and the author checked their quoted passages against the original paper. The reading found the core result sound, while the headline's stronger verbs overreached. Four recurring checks drove the analysis: converting percentages into raw counts, verifying the reagent the mechanism depends on, looking for missing comparison arms, and distinguishing mouse findings from human evidence. The author argues that scrutiny from engaged readers strengthens a claim by limiting what it can credibly assert.